Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Completed
National Cancer Institute (NCI)
Phase 2
1999-06-01
RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the
development of cancer. Applying topical imiquimod before abnormal cervical cells are removed
may be effective in preventing cervical cancer.
PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod
before abnormal cervical cells are removed in preventing cervical cancer in patients who have
recurrent or persistent cervical neoplasia.
Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Completed
Alliance for Clinical Trials in Oncology
Phase 2
1999-06-01
RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the
development of cancer. Applying topical imiquimod before abnormal cervical cells are removed
may be effective in preventing cervical cancer.
PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod
before abnormal cervical cells are removed in preventing cervical cancer in patients who have
recurrent or persistent cervical neoplasia.
Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
Completed
Queen's Medical Centre
Phase 3
2002-10-01
RATIONALE: Biological therapies such as imiquimod use different ways to stimulate the immune
system and stop cancer cells from growing. It is not yet known if topical imiquimod is more
effective than surgery in treating basal cell skin cancer.
PURPOSE: This randomized phase III trial is studying how well topical imiquimod works
compared to surgery in treating patients with basal cell skin cancer.
Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
Completed
National Naval Medical Center
Phase 1
2004-01-01
RATIONALE: Biological therapies, such as imiquimod cream, work in different ways to stimulate
the immune system and stop tumor cells from growing.
PURPOSE: This randomized phase I trial is studying how well imiquimod cream works in treating
patients with basal cell skin cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
